ZNTL
Zentalis Pharmaceuticals, Inc.
-0.02 (-0.65%)3.08USD440K成交股數221M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-10下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 3 · 45.5M · 3 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 45.5M · 0.00 |
| 近 180 天 淨額 | 45.5M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 08-19 | WALTERS SUSAN BERKLEY | TenPercentOwner | P 公開市場買進 | 4.3M | 3.50 | 15.2M | 17.8M | SEC |
| 2026-08-14 | 08-19 | WALTERS WILLIAM THURMAN | TenPercentOwner | P 公開市場買進 | 4.3M | 3.50 | 15.2M | 17.8M | SEC |
| 2026-08-14 | 08-19 | WALTERS GROUP | TenPercentOwner | P 公開市場買進 | 4.3M | 3.50 | 15.2M | 17.8M | SEC |
| 2026-06-16 | 06-18 | Skvarka Jan | Director | A 獲配股票 | 57.1K | – | – | 264K | SEC |
| 2026-06-16 | 06-18 | Myers Scott Dunseth | Director | A 獲配股票 | 57.1K | – | – | 396K | SEC |
| 2026-06-16 | 06-18 | Johnson David Michael | Director | A 獲配股票 | 57.1K | – | – | 308K | SEC |
| 2026-06-16 | 06-18 | Kariuki Enoch | Director | A 獲配股票 | 57.1K | – | – | 194K | SEC |
| 2026-06-16 | 06-18 | Walker Luke Nathaniel | Director | A 獲配股票 | 57.1K | – | – | 201K | SEC |
| 2026-05-26 | 05-27 | Campbell Shannon | Director | A 獲配股票 | 114K | – | – | 114K | SEC |
| 2026-02-10 | 02-10 | Vultaggio Vincent | PAO and PFO | S 公開市場賣出(10b5-1) | 6.9K | 2.42 | 17K | 147K | SEC |
| 2026-02-09 | 02-10 | Vultaggio Vincent | PAO and PFO | S 公開市場賣出(10b5-1) | 3.4K | 2.39 | 8K | 153K | SEC |
| 2026-02-09 | 02-10 | Bruns Ingmar | Chief Medical Officer | S 公開市場賣出 | 335 | 2.39 | 800.65 | 33.3K | SEC |
| 2026-02-09 | 02-10 | EASTLAND JULIA MARIE | CEO & President | S 公開市場賣出 | 889 | 2.39 | 2K | 79.1K | SEC |
| 2026-02-06 | 02-10 | Vultaggio Vincent | PAO and PFO | S 公開市場賣出(10b5-1) | 30.0K | 2.43 | 73K | 157K | SEC |
| 2026-02-06 | 02-10 | Bruns Ingmar | Chief Medical Officer | S 公開市場賣出 | 3.0K | 2.43 | 7K | 33.7K | SEC |
| 2026-02-06 | 02-10 | EASTLAND JULIA MARIE | CEO & President | S 公開市場賣出 | 7.9K | 2.43 | 19K | 80.0K | SEC |
| 2026-02-03 | 02-04 | Vultaggio Vincent | PAO and PFO | S 公開市場賣出(10b5-1) | 556 | 2.52 | 1K | 187K | SEC |
| 2026-02-02 | 02-04 | Vultaggio Vincent | PAO and PFO | S 公開市場賣出(10b5-1) | 2.5K | 2.55 | 6K | 187K | SEC |
| 2025-12-31 | 01-08 | WALTERS SUSAN BERKLEY | TenPercentOwner | P 公開市場買進 | 6.5M | 1.20 | 7.8M | 13.5M | SEC |
| 2025-12-31 | 01-08 | WALTERS WILLIAM THURMAN | TenPercentOwner | P 公開市場買進 | 6.5M | 1.20 | 7.8M | 13.5M | SEC |
| 2025-12-31 | 01-08 | WALTERS GROUP | TenPercentOwner | P 公開市場買進 | 6.5M | 1.20 | 7.8M | 13.5M | SEC |
| 2025-12-15 | 12-15 | Matrix Capital Management Company, LP | TenPercentOwner | S 公開市場賣出 | 7.5M | 1.33 | 10.0M | 6.5M | SEC |
| 2025-12-15 | 12-15 | GOEL DAVID E. | TenPercentOwner | S 公開市場賣出 | 7.5M | 1.33 | 10.0M | 6.5M | SEC |
| 2025-06-17 | 06-18 | Myers Scott Dunseth | Director | A 獲配股票 | 57.6K | – | – | 339K | SEC |
| 2025-06-17 | 06-18 | Kariuki Enoch | Director | A 獲配股票 | 57.6K | – | – | 137K | SEC |
| 2025-06-17 | 06-18 | Walker Luke Nathaniel | Director | A 獲配股票 | 57.6K | – | – | 144K | SEC |
| 2025-06-17 | 06-18 | Skvarka Jan | Director | A 獲配股票 | 57.6K | – | – | 207K | SEC |
| 2025-06-17 | 06-18 | Johnson David Michael | Director | A 獲配股票 | 57.6K | – | – | 250K | SEC |
| 2025-04-30 | 04-30 | Myers Scott Dunseth | Director | P 公開市場買進 | 21.0K | 1.40 | 29K | 281K | SEC |
| 2025-02-06 | 02-12 | Bruns Ingmar | Chief Medical Officer | P 公開市場買進 | 20.0K | 2.28 | 46K | 36.6K | SEC |
| 2025-02-03 | 02-05 | EASTLAND JULIA MARIE | CEO & President | A 獲配股票 | 59.4K | – | – | 87.9K | SEC |
| 2025-02-03 | 02-05 | Vultaggio Vincent | PAO and Interim PFO | S 公開市場賣出 | 2.6K | 1.71 | 4K | 190K | SEC |
| 2025-02-03 | 02-05 | Lackner Mark | Chief Scientific Officer | S 公開市場賣出 | 14.4K | 1.71 | 25K | 513K | SEC |
| 2025-02-03 | 02-05 | Vultaggio Vincent | PAO and Interim PFO | A 獲配股票 | 159K | – | – | 192K | SEC |
| 2025-02-03 | 02-05 | Paul Andrea | Chief Legal Officer | A 獲配股票 | 934K | – | – | 1.1M | SEC |
| 2025-02-03 | 02-05 | Lackner Mark | Chief Scientific Officer | A 獲配股票 | 336K | – | – | 527K | SEC |
| 2025-02-03 | 02-05 | Bruns Ingmar | Chief Medical Officer | A 獲配股票 | 16.6K | – | – | 16.6K | SEC |
| 2025-02-03 | 02-05 | Paul Andrea | Chief Legal Officer | S 公開市場賣出 | 13.2K | 1.71 | 23K | 1.1M | SEC |
| 2025-01-31 | 02-04 | EASTLAND JULIA MARIE | CEO & President | P 公開市場買進 | 28.5K | 1.73 | 49K | 28.5K | SEC |
| 2025-01-31 | 02-04 | Skvarka Jan | Director | P 公開市場買進 | 60.0K | 1.72 | 103K | 150K | SEC |
| 2025-01-31 | 02-04 | Walker Luke Nathaniel | Director | P 公開市場買進 | 14.2K | 1.76 | 25K | 86.7K | SEC |
| 2025-01-02 | 01-03 | Lackner Mark | Chief Scientific Officer | S 公開市場賣出 | 4.4K | 3.12 | 14K | 191K | SEC |
| 2024-11-13 | 11-13 | Myers Scott Dunseth | Director | A 獲配股票 | 260K | – | – | 260K | SEC |
| 2024-10-04 | 10-04 | Vultaggio Vincent | Principal Accounting Officer | S 公開市場賣出(10b5-1) | 1.6K | 3.18 | 5K | 33.9K | SEC |
| 2024-06-21 | 06-21 | Johnson David Michael | Director | A 獲配股票 | 48.4K | – | – | 193K | SEC |
| 2024-06-21 | 06-21 | Skvarka Jan | Director | A 獲配股票 | 41.6K | – | – | 89.6K | SEC |
| 2024-06-21 | 06-21 | Kariuki Enoch | Director | A 獲配股票 | 41.6K | – | – | 79.8K | SEC |
| 2024-05-31 | 05-31 | Gallagher Cam | President, Interim CFO | S 公開市場賣出 | 9.6K | 11.98 | 115K | 634K | SEC |
| 2024-05-24 | 05-29 | Walker Luke Nathaniel | Director | A 獲配股票 | 72.5K | – | – | 72.5K | SEC |
| 2024-05-09 | 05-09 | HAUSMAN DIANA | Chief Medical Officer | S 公開市場賣出 | 3.4K | 12.62 | 42K | 374K | SEC |
| 2024-02-12 | 02-12 | Epperly Melissa B, | Chief Financial Officer | S 公開市場賣出 | 2.6K | 11.44 | 29K | 451K | SEC |
| 2024-02-12 | 02-12 | Gallagher Cam | President | S 公開市場賣出 | 1.2K | 11.44 | 13K | 643K | SEC |
| 2024-02-02 | 02-05 | Paul Andrea | Chief Legal Officer | S 公開市場賣出 | 3.3K | 11.54 | 38K | 150K | SEC |
| 2024-02-02 | 02-05 | Gallagher Cam | President | S 公開市場賣出 | 11.6K | 11.54 | 133K | 644K | SEC |
| 2024-02-02 | 02-05 | Epperly Melissa B, | Chief Financial Officer | S 公開市場賣出 | 8.7K | 11.54 | 100K | 454K | SEC |
| 2024-02-02 | 02-05 | Lackner Mark | Chief Scientific Officer | S 公開市場賣出 | 1.6K | 11.54 | 18K | 196K | SEC |
| 2024-02-01 | 02-05 | HAUSMAN DIANA | Chief Medical Officer | A 獲配股票 | 338K | – | – | 377K | SEC |
| 2024-02-01 | 02-05 | Lackner Mark | Chief Scientific Officer | A 獲配股票 | 141K | – | – | 197K | SEC |
| 2024-02-01 | 02-05 | Paul Andrea | Chief Legal Officer | A 獲配股票 | 113K | – | – | 153K | SEC |
| 2024-02-01 | 02-05 | Gallagher Cam | President | A 獲配股票 | 193K | – | – | 656K | SEC |
| 2024-02-01 | 02-05 | Epperly Melissa B, | Chief Financial Officer | A 獲配股票 | 75.0K | – | – | 463K | SEC |
| 2024-02-01 | 02-05 | Blackwell Kimberly | Chief Executive Officer | F 繳稅扣股 | 20.7K | 11.69 | 241K | 484K | SEC |
| 2024-02-01 | 02-05 | Blackwell Kimberly | Chief Executive Officer | A 獲配股票 | 250K | – | – | 505K | SEC |
| 2024-01-02 | 01-03 | Lackner Mark | Chief Scientific Officer | A 獲配股票 | 40.0K | – | – | 56.3K | SEC |
| 2023-12-20 | 12-21 | Bunker Kevin D. | Chief Scientific Officer | G 贈與 | 24.2K | – | – | 835K | SEC |
| 2023-11-13 | 11-13 | Blackwell Kimberly | Chief Executive Officer | P 公開市場買進 | 5.0K | 10.29 | 51K | 255K | SEC |
| 2023-11-10 | 11-13 | Johnson David Michael | Director | P 公開市場買進 | 17.0K | 9.88 | 168K | 144K | SEC |
| 2023-10-04 | 10-06 | Epperly Melissa B, | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.6K | 19.43 | 89K | 389K | SEC |
| 2023-10-04 | 10-06 | Epperly Melissa B, | Chief Financial Officer | S 公開市場賣出(10b5-1) | 888 | 19.91 | 18K | 388K | SEC |
| 2023-10-04 | 10-06 | Brownstein Carrie | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.7K | 19.91 | 34K | 106K | SEC |
| 2023-10-04 | 10-06 | Brownstein Carrie | Chief Medical Officer | S 公開市場賣出(10b5-1) | 8.9K | 19.43 | 173K | 107K | SEC |
| 2023-10-04 | 10-06 | Bunker Kevin D. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 5.1K | 19.43 | 99K | 860K | SEC |
| 2023-10-04 | 10-06 | Bunker Kevin D. | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 983 | 19.91 | 20K | 859K | SEC |
| 2023-09-11 | 09-13 | Skvarka Jan | Director | S 公開市場賣出(10b5-1) | 5.0K | 25.05 | 125K | 48.0K | SEC |
| 2023-06-20 | 06-20 | GOEL DAVID E. | TenPercentOwner | P 公開市場買進 | 4.8M | 22.66 | 108M | 14.0M | SEC |
| 2023-06-20 | 06-20 | Matrix Capital Management Company, LP | TenPercentOwner | P 公開市場買進 | 4.8M | 22.66 | 108M | 14.0M | SEC |
| 2023-06-16 | 06-16 | Kariuki Enoch | Director | A 獲配股票 | 16.4K | – | – | 38.2K | SEC |
| 2023-06-16 | 06-16 | Johnson David Michael | Director | A 獲配股票 | 19.1K | – | – | 127K | SEC |
| 2023-06-16 | 06-16 | Skvarka Jan | Director | A 獲配股票 | 16.4K | – | – | 53.0K | SEC |
| 2023-05-31 | 05-31 | Gallagher Cam | President | S 公開市場賣出(10b5-1) | 9.2K | 26.40 | 244K | 482K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| 5AM Venture Management, LLC | 3.9M | 19.1M | 新進 | 新進 |
| BlackRock, Inc. | 3.8M | 18.2M | 新進 | 新進 |
| Squadron Capital Management LLC | 3.7M | 17.9M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 3.0M | 14.7M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.8M | 13.8M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 2.3M | 11.1M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 1.6M | 7.8M | 新進 | 新進 |
| Opaleye Management Inc. | 1.4M | 6.9M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 1.4M | 6.7M | 新進 | 新進 |
| Decheng Capital LLC | 1.3M | 6.4M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3M | 6.2M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 1.1M | 5.4M | 新進 | 新進 |
| Ishara Investments LP | 1.0M | 5.0M | 新進 | 新進 |
| PRIMECAP MANAGEMENT CO/CA/ | 957K | 4.6M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 950K | 4.6M | 新進 | 新進 |
| STATE STREET CORP | 887K | 4.3M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 809K | 3.9M | 新進 | 新進 |
| Pfizer Inc | 954K | 3.9M | 新進 | 新進 |
| Connor, Clark & Lunn Investment Management Ltd. | 758K | 3.7M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 664K | 3.2M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 653K | 3.2M | 新進 | 新進 |
| MARSHALL WACE, LLP | 591K | 2.9M | 新進 | 新進 |
| Qube Research & Technologies Ltd | 575K | 2.8M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 547K | 2.7M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 543K | 2.6M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 114 +12 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 114 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 47.4M · 66.1% |
| 合計季末市值 | 214M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 5.0M |
|---|---|
| 與上期比 | -16.5% |
| 佔流通股數 | 6.96% |
| 日均成交量 | 972K |
| 回補天數 | 5.1 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 5.0M | -16.5% | 6.96% | 972K | 5.1 |
| 2026-08-14 | 6.0M | +7.0% | 8.33% | 1.1M | 5.3 |
| 2026-07-31 | 5.6M | -9.2% | 7.78% | 1.3M | 4.2 |
| 2026-07-15 | 6.1M | +4.7% | 8.58% | 972K | 6.3 |
| 2026-06-30 | 5.9M | +17.8% | 8.19% | 1.8M | 3.2 |
| 2026-06-15 | 5.0M | -0.8% | 6.95% | 883K | 5.6 |
| 2026-05-29 | 5.0M | +1.9% | 7.00% | 984K | 5.1 |
| 2026-05-15 | 4.9M | -10.3% | 6.87% | 889K | 5.5 |
| 2026-04-30 | 5.5M | +5.5% | 7.66% | 1.4M | 3.9 |
| 2026-04-15 | 5.2M | +22.1% | 7.26% | 7.6M | 1.0 |
| 2026-03-31 | 4.3M | +2.1% | 5.94% | 501K | 8.5 |
| 2026-03-13 | 4.2M | +10.5% | 5.82% | 767K | 5.4 |
| 2026-02-27 | 3.8M | -0.1% | 5.27% | 629K | 6.0 |
| 2026-02-13 | 3.8M | -6.1% | 5.27% | 604K | 6.3 |
| 2026-01-30 | 4.0M | -16.6% | 5.62% | 751K | 5.4 |
| 2026-01-15 | 4.8M | +17.5% | 6.74% | 4.4M | 1.1 |
| 2025-12-31 | 4.1M | -25.2% | 5.74% | 1.0M | 4.0 |
| 2025-12-15 | 5.5M | +7.2% | 7.67% | 497K | 11.1 |
| 2025-11-28 | 5.1M | +0.9% | 7.16% | 508K | 10.1 |
| 2025-11-14 | 5.1M | +1.9% | 7.09% | 705K | 7.2 |
| 2025-10-31 | 5.0M | +1.1% | 6.96% | 711K | 7.0 |
| 2025-10-15 | 4.9M | +11.8% | 6.89% | 738K | 6.7 |
| 2025-09-30 | 4.4M | -2.8% | 6.16% | 729K | 6.1 |
| 2025-09-15 | 4.5M | +1.3% | 6.34% | 612K | 7.4 |
| 2025-08-29 | 4.5M | +0.5% | 6.26% | 964K | 4.7 |
| 2025-08-15 | 4.5M | -5.2% | 6.23% | 654K | 6.8 |